Home Cart 0 Sign in  
X

[ CAS No. 383-53-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 383-53-9
Chemical Structure| 383-53-9
Chemical Structure| 383-53-9
Structure of 383-53-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 383-53-9 ]

Related Doc. of [ 383-53-9 ]

Alternatived Products of [ 383-53-9 ]

Product Details of [ 383-53-9 ]

CAS No. :383-53-9 MDL No. :MFCD00126489
Formula : C9H6BrF3O Boiling Point : -
Linear Structure Formula :- InChI Key :HEMROKPXTCOASZ-UHFFFAOYSA-N
M.W : 267.04 Pubchem ID :321979
Synonyms :

Calculated chemistry of [ 383-53-9 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 49.51
TPSA : 17.07 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.75 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.99
Log Po/w (XLOGP3) : 3.07
Log Po/w (WLOGP) : 4.44
Log Po/w (MLOGP) : 3.24
Log Po/w (SILICOS-IT) : 3.75
Consensus Log Po/w : 3.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.55
Solubility : 0.0755 mg/ml ; 0.000283 mol/l
Class : Soluble
Log S (Ali) : -3.1
Solubility : 0.214 mg/ml ; 0.000803 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.49
Solubility : 0.00862 mg/ml ; 0.0000323 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.68

Safety of [ 383-53-9 ]

Signal Word:Danger Class:8
Precautionary Statements:P260-P264-P270-P280-P301+P312+P330-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P362+P364-P405-P501 UN#:3261
Hazard Statements:H302+H312-H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 383-53-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 383-53-9 ]
  • Downstream synthetic route of [ 383-53-9 ]

[ 383-53-9 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 383-53-9 ]
  • [ 77287-34-4 ]
  • [ 37148-86-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 15, p. 3540 - 3546
[2] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 10, p. 2724 - 2728
[3] Journal of Chemical Research, 2014, vol. 38, # 4, p. 208 - 210
  • 2
  • [ 383-53-9 ]
  • [ 1891-90-3 ]
Reference: [1] Organic and Biomolecular Chemistry, 2017, vol. 15, # 46, p. 9889 - 9894
  • 3
  • [ 313343-88-3 ]
  • [ 383-53-9 ]
YieldReaction ConditionsOperation in experiment
82% at 40℃; for 6 h; Green chemistry General procedure: A mixture of haloalkyne (0.5 mmol), AgF (5molpercent) and water (1 equiv.) in TFA (1 mL) was stirred at 40°C for 6h, after which TFA was distilled out for reuse. The residue was separated by column chromatography to give the pure sample.
80% With indium(III) triflate; water In acetic acid at 100℃; Sealed tube General procedure: The reaction mixture of In(OTf)3 (16.8mg, 0.03mmol), 1-haloalkynes (0.3mmol), H2O (0.9mmol), HOAc (0.6mL), in a 5mL sealed tube was stirred at 100°C and monitored periodically by TLC. Upon completion, HOAc was removed under reduced pressure using an aspirator, and then the residue was purified by flash chromatography (PE/EA) on silica gel to afford corresponding carbonyl compounds 2a–2ad.
80% With tetrafluoroboric acid; water In 2,2,2-trifluoroethanol at 80℃; for 2 h; General procedure: A mixture of haloalkyne (0.2 mmol), tetrafluoroboric acid (20 molpercent, 40percent  aqueous solution ) in 2,2,2-trifluoroethanol (1 mL) was stirred at 80°C for 2 or 10 h. After the reaction was finished, water (5 mL) was added and the solution was extracted with ethyl acetate (3×5 mL), the combined extract was dried with anhydrous MgSO4. Solvent was removed, and the residue was separated by column chromatography to give the pure sample.
Reference: [1] Tetrahedron Letters, 2014, vol. 55, # 7, p. 1373 - 1375
[2] European Journal of Organic Chemistry, 2016, vol. 2016, # 1, p. 116 - 121
[3] Tetrahedron, 2016, vol. 72, # 27-28, p. 3818 - 3822
[4] Tetrahedron Letters, 2016, vol. 57, # 45, p. 4983 - 4986
[5] Chinese Journal of Chemistry, 2016, vol. 34, # 12, p. 1251 - 1254
  • 4
  • [ 709-63-7 ]
  • [ 556110-56-6 ]
  • [ 383-53-9 ]
YieldReaction ConditionsOperation in experiment
63% With trimethylsilyl bromide; potassium nitrate In dichloromethane at 20℃; for 16 h; General procedure: In a Nalgene.(R). bottle, to acetophenone (2 mmol) in dichloromethane (10 mL), potassium nitrate (4 mmol) and chloro/bromotrimethylsilane (8 mmol) were added. The heterogeneous mixture was stirred vigorously at 60 °C (for chlorination) or room temperature (for bromination) until the reaction went to completion (monitored by 1H NMR spectroscopy). The reaction mixture was then filtered and solvent removed under reduced pressure. The chlorinated/brominated acetophenone derivatives were obtained upon purification by flash chromatography (silica gel) with hexane as eluent. The products were characterized by comparing their spectroscopic data with those of the authentic samples.
0.6% With bromine; sodium hydrogencarbonate; acetic acid; sodium chloride In hexane; water; ethyl acetate Example 41
2,2-Dibromo-1-(4-trifluoromethyl-phenyl)-ethanone.
This compound was synthesised by the general procedure represented in Scheme 2, a stirred solution of 1-(4-trifluoromethyl-phenyl)-ethanone (1 g, 5.3 mmol)) and acetic acid (50 ml) was refluxed 1 h, then bromine (0.35 ml, 6.9 mmol) was added dropwise and the mixture refluxed 3 h.
After cooling at room temperature, water (50 ml) was added and the mixture extracted with CH2Cl2 (50 ml), the organic layer was washed with water (50 ml), a solution of NaHCO3 saturated (50 ml) and finally with NaCl solution (50 ml), the organic layer was dried over sodium sulphate and the solvent evaporated under reduced pressure.
The resulting residue was purified by column chromatography, using a mixture of ethyl acetate:hexane (1:8) as eluent giving two compounds, the titled compound 41 as a yellow solid (45percent) m.p.: 40-41° C., 1H-NMR (CDCl3): δ8.2 (d, J=8.3 Hz, 2H, Ar), 7.8 (d, J=8.3 Hz, 2H, Ar), 6.6 (s, 1H, CH); 13C-NMR (CDCl3): δ184.1 (CO), 134.7 (q, J=272.9 Hz, C-CF3), 132.7 (C-CO), 129.2 (CH), 124.8 (CH), 119.5 (q, J=33.09, CF3), 38.2 (CH); M/z (EI): 348, 346, 344 (M+, 1, 6, 1percent), 173 (M-CHBr2, 100percent); HPLC: Column μ Bondapack C18, 5 μm, 300 A, (300*3.9 mm), Purity 97percent, r.t.=9.96 min, acetonitrile/H2O (0.05percent H3PO4+0.04percent Et3N) 50/50.
The second compound was identified as 2-bromo-1-(4-trifluoromethyl-phenyl)-ethanone (0,6percent), described as the example 40.
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 11, p. 1217 - 1221
[2] Journal of Medicinal Chemistry, 2011, vol. 54, # 12, p. 4042 - 4056
[3] Patent: US2003/199508, 2003, A1,
[4] Biochemistry, 2010, vol. 49, # 36, p. 7913 - 7919
  • 5
  • [ 709-63-7 ]
  • [ 383-53-9 ]
YieldReaction ConditionsOperation in experiment
87% With N-Bromosuccinimide In ethyl acetate at 40℃; 10 mmol 4-trifluoromethyl acetophenone is added to a 100 mL round bottom flaskAnd 11mmol of N-bromosuccinimide (NBS),35mL of ethyl acetate dissolved,Then add 1g of Amberlyst 15 ion exchange resin as catalyst.The reaction solution was warmed to 40°C to react. After TLC tracks the reaction,The reaction solution was filtered to remove Amberlyst 15 ion exchange resin,The filtrate was evaporated to dryness and column chromatography (eluent: petroleum ether/dichloromethane) gave white crystals.Yield 87percent.
Reference: [1] Journal of Medicinal Chemistry, 2001, vol. 44, # 20, p. 3231 - 3243
[2] Organic and Biomolecular Chemistry, 2007, vol. 5, # 16, p. 2690 - 2697
[3] Patent: CN107629022, 2018, A, . Location in patent: Paragraph 0473; 0474; 0475; 0476
[4] Journal of agricultural and food chemistry, 2002, vol. 50, # 12, p. 3486 - 3490
[5] Journal of Pharmaceutical Sciences, 2014, vol. 103, # 9, p. 2797 - 2808
[6] Tetrahedron, 2008, vol. 64, # 22, p. 5191 - 5199
[7] Journal of the American Chemical Society, 1953, vol. 75, p. 5884,5886
[8] Journal of Physical Chemistry, 1995, vol. 99, # 20, p. 8190 - 8195
[9] Journal of Medicinal Chemistry, 1996, vol. 39, # 1, p. 253 - 266
[10] Bioorganic and medicinal chemistry, 2002, vol. 10, # 3, p. 507 - 515
[11] Journal of medicinal chemistry, 1972, vol. 15, # 9, p. 989 - 994
[12] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 21, p. 3047 - 3050
[13] Tetrahedron, 2003, vol. 59, # 8, p. 1317 - 1325
[14] Journal of Medicinal Chemistry, 2007, vol. 50, # 3, p. 528 - 542
[15] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 6, p. 1746 - 1749
[16] Tetrahedron, 2008, vol. 64, # 22, p. 5191 - 5199
[17] Patent: WO2010/129665, 2010, A2, . Location in patent: Page/Page column 109
[18] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 7, p. 2316 - 2322
[19] European Journal of Medicinal Chemistry, 2012, vol. 52, p. 70 - 81
[20] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 7, p. 2031 - 2034
[21] Journal of Organic Chemistry, 2013, vol. 78, # 12, p. 6276 - 6280
[22] Angewandte Chemie - International Edition, 2013, vol. 52, # 44, p. 11632 - 11636[23] Angew. Chem., 2013, vol. 125, # 44, p. 11846 - 11850,5
[24] Chemistry - A European Journal, 2014, vol. 20, # 20, p. 5983 - 5993
[25] Journal of Medicinal Chemistry, 2014, vol. 57, # 15, p. 6572 - 6582
[26] European Journal of Organic Chemistry, 2014, vol. 2014, # 34, p. 7707 - 7715
[27] Drug Design, Development and Therapy, 2016, vol. 10, p. 1807 - 1815
[28] Patent: CN105315279, 2016, A, . Location in patent: Paragraph 0112
[29] Organic Letters, 2017, vol. 19, # 8, p. 1994 - 1997
[30] Organic Letters, 2017, vol. 19, # 11, p. 2877 - 2880
[31] Organic and Biomolecular Chemistry, 2017, vol. 15, # 38, p. 8134 - 8139
[32] Patent: WO2017/198341, 2017, A1, . Location in patent: Page/Page column 868
[33] Patent: US2018/44284, 2018, A1, . Location in patent: Paragraph 0169; 0170
[34] European Journal of Medicinal Chemistry, 2018, vol. 157, p. 310 - 319
[35] Tetrahedron Letters, 2018, vol. 59, # 33, p. 3214 - 3219
[36] Chemical Communications (Cambridge, United Kingdom), 2018, vol. 54, # 86, p. 12182 - 12185
  • 6
  • [ 1616490-76-6 ]
  • [ 383-53-9 ]
Reference: [1] Chemical Communications, 2017, vol. 53, # 49, p. 6565 - 6568
  • 7
  • [ 709-63-7 ]
  • [ 107-21-1 ]
  • [ 658680-40-1 ]
  • [ 556110-56-6 ]
  • [ 383-53-9 ]
YieldReaction ConditionsOperation in experiment
3.4 - 11.7 %Chromat. With bromine In chloroform at 25 - 28℃; for 3.5 - 24 h; 2.82g (14. [99MMOL, LEQ.) OF 4APOS;-TRIFLUOROMETHYLACETOPHENONE] were dissolved in 7. [5ML] (8. 35g, 134. [53MMOL,] 8.97eq.) of ethylene glycol. While the solution was controlled to have an internal temperature [OF 25-28APOS;C,] a chloroform solution obtained by diluting 3.60g (22.53mmol, 1.50eq.) [OF BR2] with 2. [2ML] of chloroform was added to the solution, followed by stirring for 24hr with an internal temperature [OF 25-26C.] 3.5hr and 24hr after the start of the reaction, the progress of the reaction was checked by gas chromatography. The results are shown in Table 3. Table 3 Time Compound A1 C1 D 3. 5h 11. 7percent 54. 2percent 0. 3percent 24h 3. 4percent 88. 6percent 0. 8percent 1 : Compound A Compound C Compound D ouzo Br p Br bu Xf, () I CF) ()' Br L'r'3
91.09 %Chromat. With bromine In chloroform at 28 - 32℃; for 15 h; [106G (0. 56MOL, LEQ. ) OF 4APOS;-TRIFLUOROMETHYLACETOPHENONE WERE DISSOLVED] in [281ML] (313g, 5. [04MOL,] 9. [00EQ.)] of ethylene glycol. While the solution was controlled to have an internal temperature [OF 28-32C,] a chloroform solution obtained by diluting 108g (0. 68mol, 1.21eq.) of Br2 with [56ML] of chloroform was added to the solution, followed by stirring for [15HR] with an internal temperature of [29-32DUC.] The resulting reaction separated into an upper and lower layer. Then, the lower layer was washed with [2percent BRINE,] followed by drying with anhydrous sodium sulfate, filtration and vacuum drying, thereby obtaining 165g of a crude product of a brominated acetal represented by the following formula. The yield was 94percent. The analytical results of the crude product by gas chromatography are shown in Table 4, and [ITS 1H-NMR] spectrum was as follows. Table 4 Compound A1 C1 D1 Total Others 0. 6percent 96. 9percent 0. 9percent 1. 6percent 1 : Compound A Compound C Compound D o n o Br p Br 'bu ZIG CF3 CF CF3 3 [1H-NMR] (standard substance: TMS, solvent: [CDCL3),] [8PPM] : 3.64 (s, 2H), 3.83-3. 98 (m, 2H), 4.14-4. 30 (m, 2H), 7.64 (Ar-H, 4H). Separately, water was poured into the above-obtained upper layer, followed by extraction with ethyl acetate. The collected organic layer was dried with anhydrous sodium sulfate, followed by filtration, concentration and vacuum drying, thereby obtaining 6g of a brominated acetal of the above formula. The yield was 3percent.
Reference: [1] Patent: WO2004/14887, 2004, A1, . Location in patent: Page 11; 24
[2] Patent: WO2004/14887, 2004, A1, . Location in patent: Page 11; 25-26
  • 8
  • [ 67-56-1 ]
  • [ 709-63-7 ]
  • [ 556110-56-6 ]
  • [ 383-53-9 ]
YieldReaction ConditionsOperation in experiment
26.0 - 29.2 %Chromat. at 26 - 28℃; for 3.5 - 24 h; [2. 82G (14. 99MMOL, LEQ. ) OF 4APOS;-TRIFLUOROMETHYLACETOPHENONE WERE] dissolved in 5. [6ML] of methanol. While the solution was controlled to have an internal temperature [OF 26-27C,] a methanol solution obtained by diluting 3.60g (22. [53MMOL,] 1.50eq.) of Br2 with [1.] [4ML] of methanol was added to the solution, followed by stirring for 24hr with an internal temperature [OF 26-28C.] 3.5hr and 24hr after the start of the reaction, the progress of the reaction was checked by gas chromatography. The results are shown in Table 2. Table 2 Time Compound A1 B1 D 3. 5h 29. 2percent 53. 8percent 9. 5percent 24h 26. 0percent 45. 3percent 25. 3percent : Compound A Compound B Compound D 0 CH30 OCH3 0 Br I Br Br / CF) () CF3 CF-Br 3 3
Reference: [1] Patent: WO2004/14887, 2004, A1, . Location in patent: Page 11; 23-24
  • 9
  • [ 705-31-7 ]
  • [ 383-53-9 ]
Reference: [1] Green Chemistry, 2017, vol. 19, # 8, p. 1983 - 1989
  • 10
  • [ 402-50-6 ]
  • [ 383-53-9 ]
Reference: [1] Organic and Biomolecular Chemistry, 2017, vol. 15, # 46, p. 9889 - 9894
  • 11
  • [ 383-53-9 ]
  • [ 339-58-2 ]
Reference: [1] Journal of the American Chemical Society, 2011, vol. 133, # 19, p. 7312 - 7315
  • 12
  • [ 383-53-9 ]
  • [ 77287-34-4 ]
  • [ 1126636-40-5 ]
Reference: [1] Organic Letters, 2011, vol. 13, # 6, p. 1474 - 1477
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 383-53-9 ]

Fluorinated Building Blocks

Chemical Structure| 537050-14-9

[ 537050-14-9 ]

2-Bromo-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone

Similarity: 0.87

Chemical Structure| 30071-93-3

[ 30071-93-3 ]

1-(3,5-Bis(trifluoromethyl)phenyl)ethanone

Similarity: 0.85

Chemical Structure| 349-76-8

[ 349-76-8 ]

3'-(Trifluoromethyl)acetophenone

Similarity: 0.85

Chemical Structure| 85068-34-4

[ 85068-34-4 ]

1-(3,5-Bis(trifluoromethyl)phenyl)propan-1-one

Similarity: 0.83

Chemical Structure| 711-33-1

[ 711-33-1 ]

1-(4-(Trifluoromethyl)phenyl)propan-1-one

Similarity: 0.83

Aryls

Chemical Structure| 537050-14-9

[ 537050-14-9 ]

2-Bromo-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone

Similarity: 0.87

Chemical Structure| 30071-93-3

[ 30071-93-3 ]

1-(3,5-Bis(trifluoromethyl)phenyl)ethanone

Similarity: 0.85

Chemical Structure| 349-76-8

[ 349-76-8 ]

3'-(Trifluoromethyl)acetophenone

Similarity: 0.85

Chemical Structure| 85068-34-4

[ 85068-34-4 ]

1-(3,5-Bis(trifluoromethyl)phenyl)propan-1-one

Similarity: 0.83

Chemical Structure| 711-33-1

[ 711-33-1 ]

1-(4-(Trifluoromethyl)phenyl)propan-1-one

Similarity: 0.83

Bromides

Chemical Structure| 537050-14-9

[ 537050-14-9 ]

2-Bromo-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone

Similarity: 0.87

Chemical Structure| 154259-25-3

[ 154259-25-3 ]

3'-Bromo-5'-(trifluoromethyl)acetophenone

Similarity: 0.77

Chemical Structure| 130365-87-6

[ 130365-87-6 ]

1-(2-Bromoethyl)-4-(trifluoromethyl)benzene

Similarity: 0.77

Chemical Structure| 1131605-31-6

[ 1131605-31-6 ]

1-(2-Bromo-4-(trifluoromethyl)phenyl)ethanone

Similarity: 0.76

Chemical Structure| 403-29-2

[ 403-29-2 ]

2-Bromo-1-(4-fluorophenyl)ethanone

Similarity: 0.75

Ketones

Chemical Structure| 537050-14-9

[ 537050-14-9 ]

2-Bromo-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone

Similarity: 0.87

Chemical Structure| 30071-93-3

[ 30071-93-3 ]

1-(3,5-Bis(trifluoromethyl)phenyl)ethanone

Similarity: 0.85

Chemical Structure| 349-76-8

[ 349-76-8 ]

3'-(Trifluoromethyl)acetophenone

Similarity: 0.85

Chemical Structure| 85068-34-4

[ 85068-34-4 ]

1-(3,5-Bis(trifluoromethyl)phenyl)propan-1-one

Similarity: 0.83

Chemical Structure| 711-33-1

[ 711-33-1 ]

1-(4-(Trifluoromethyl)phenyl)propan-1-one

Similarity: 0.83

Trifluoromethyls

Chemical Structure| 537050-14-9

[ 537050-14-9 ]

2-Bromo-1-(4-fluoro-3-(trifluoromethyl)phenyl)ethanone

Similarity: 0.87

Chemical Structure| 30071-93-3

[ 30071-93-3 ]

1-(3,5-Bis(trifluoromethyl)phenyl)ethanone

Similarity: 0.85

Chemical Structure| 349-76-8

[ 349-76-8 ]

3'-(Trifluoromethyl)acetophenone

Similarity: 0.85

Chemical Structure| 85068-34-4

[ 85068-34-4 ]

1-(3,5-Bis(trifluoromethyl)phenyl)propan-1-one

Similarity: 0.83

Chemical Structure| 711-33-1

[ 711-33-1 ]

1-(4-(Trifluoromethyl)phenyl)propan-1-one

Similarity: 0.83